Found: 33
Select item for more details and to access through your institution.
2-deoxy-D-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II clinical trial.
- Published in:
- BMC Infectious Diseases, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12879-022-07642-6
- By:
- Publication type:
- Article
Tepilamide Fumarate (PPC-06) Extended Release Tablets in Patients with Moderate-to-Severe Plaque Psoriasis: Safety and Efficacy Results from the Randomized, Double-blind, Placebo-controlled AFFIRM Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Tolerability, and Safety of Celecoxib Oral Solution (ELYXYB) in Acute Treatment of Episodic Migraine with or without Aura.
- Published in:
- Journal of Pain Research, 2021, v. 14, p. 2529, doi. 10.2147/JPR.S322292
- By:
- Publication type:
- Article
Acute Treatment of Migraine with Celecoxib Oral Solution: Results of a Randomized, Placebo-Controlled Clinical Trial.
- Published in:
- Journal of Pain Research, 2021, v. 14, p. 549, doi. 10.2147/JPR.S287571
- By:
- Publication type:
- Article
Burden of increasing opioid use in the treatment of migraine: Results from the Migraine in America Symptoms and Treatment Study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 1, p. 103, doi. 10.1111/head.14018
- By:
- Publication type:
- Article
Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study.
- Published in:
- Journal of Headache & Pain, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s10194-020-1084-y
- By:
- Publication type:
- Article
Most Bothersome Symptom in Persons With Migraine: Results From the Migraine in America Symptoms and Treatment (MAST) Study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 2, p. 416, doi. 10.1111/head.13708
- By:
- Publication type:
- Article
Treatment patterns of patients diagnosed with major headache disorders: A retrospective claims analysis.
- Published in:
- Cephalalgia Reports, 2020, v. 3, p. 1, doi. 10.1177/2515816320913992
- By:
- Publication type:
- Article
Efficacy, Tolerability, and Safety of DFN‐15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 1, p. 58, doi. 10.1111/head.13663
- By:
- Publication type:
- Article
Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2019, v. 59, n. 8, p. 1310, doi. 10.1111/head.13588
- By:
- Publication type:
- Article
Predictors of allodynia in persons with migraine: Results from the Migraine in America Symptoms and Treatment (MAST) study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
DFN-02, Sumatriptan 10 mg Nasal Spray with Permeation Enhancer, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Study Assessing Functional Disability and Subject Satisfaction with Treatment.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
- Published in:
- Headache: The Journal of Head & Face Pain, 2018, v. 58, n. 9, p. 1408, doi. 10.1111/head.13407
- By:
- Publication type:
- Article
Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled study.
- Published in:
- Journal of Headache & Pain, 2018, v. 19, n. 1, p. 1, doi. 10.1186/s10194-018-0881-z
- By:
- Publication type:
- Article
Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: an 8-week open-label extension study.
- Published in:
- Journal of Headache & Pain, 2018, v. 19, n. 1, p. 1, doi. 10.1186/s10194-018-0882-y
- By:
- Publication type:
- Article
Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study.
- Published in:
- Journal of Headache & Pain, 2018, v. 19, n. 1, p. 1, doi. 10.1186/s10194-018-0865-z
- By:
- Publication type:
- Article
DFN‐02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double‐Blind, Placebo‐Controlled Study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2018, v. 58, n. 5, p. 676, doi. 10.1111/head.13309
- By:
- Publication type:
- Article
Pharmacokinetic Characterization and Dose Selection of a Novel Sumatriptan Nasal Spray Formulation, DFN-02.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 11, p. 1472, doi. 10.1002/jcph.946
- By:
- Publication type:
- Article
Efficacy and safety of DFN-15, an oral liquid formulation of celecoxib, in adults with migraine: a multicenter, randomized, placebo-controlled, double-blind, crossover study.
- Published in:
- Neuropsychiatric Disease & Treatment, 2017, v. 13, p. 2797, doi. 10.2147/NDT.S151834
- By:
- Publication type:
- Article
Pharmacokinetics of DFN-15, a Novel Oral Solution of Celecoxib, Versus Celecoxib 400-mg Capsules: A Randomized Crossover Study in Fasting Healthy Volunteers.
- Published in:
- Clinical Drug Investigation, 2017, v. 37, n. 10, p. 937, doi. 10.1007/s40261-017-0548-6
- By:
- Publication type:
- Article
Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results from the American Migraine Prevalence and Prevention Study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2017, v. 57, n. 7, p. 1026, doi. 10.1111/head.13115
- By:
- Publication type:
- Article
A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine.
- Published in:
- Journal of Headache & Pain, 2017, v. 18, n. 1, p. 1, doi. 10.1186/s10194-017-0740-3
- By:
- Publication type:
- Article
Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine.
- Published in:
- Journal of Headache & Pain, 2017, v. 18, n. 1, p. 1, doi. 10.1186/s10194-016-0717-7
- By:
- Publication type:
- Article
Subcutaneous sumatriptan delivery devices: comparative ease of use and preference among migraineurs.
- Published in:
- Patient Preference & Adherence, 2017, v. 11, p. 121, doi. 10.2147/PPA.S125137
- By:
- Publication type:
- Article
Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention ( AMPP) Study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2016, v. 56, n. 10, p. 1635, doi. 10.1111/head.12941
- By:
- Publication type:
- Article
A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.
- Published in:
- Headache: The Journal of Head & Face Pain, 2016, v. 56, n. 9, p. 1455, doi. 10.1111/head.12905
- By:
- Publication type:
- Article
The effect of weight, body mass index, age, sex, and race on plasma concentrations of subcutaneous sumatriptan: a pooled analysis.
- Published in:
- Clinical Pharmacology, 2016, v. 8, p. 109, doi. 10.2147/CPAA.S108966
- By:
- Publication type:
- Article
Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients.
- Published in:
- Medical Devices: Evidence & Research, 2016, v. 9, p. 131, doi. 10.2147/MDER.S105899
- By:
- Publication type:
- Article
Safety and Pharmacokinetics of Single and Multiple Intravenous Bolus Doses of Diclofenac Sodium Compared With Oral Diclofenac Potassium 50mg: A Randomized, Parallel-Group, Single-Center Study in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 1, p. 87, doi. 10.1002/jcph.575
- By:
- Publication type:
- Article
Population estimates for biomarkers of exposure to cigarette smoke in adult U.S. cigarette smokers.
- Published in:
- Nicotine & Tobacco Research, 2009, v. 11, n. 10, p. 1216, doi. 10.1093/ntr/ntp126
- By:
- Publication type:
- Article
Heart Rate Variability Increases With Reductions in Cigarette Smoke Exposure After 3 Days.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 2009, v. 14, n. 3, p. 192, doi. 10.1177/1074248409340340
- By:
- Publication type:
- Article
Effects of Different Levels of Cigarette Smoke Exposure on Prognostic Heart Rate and Rate--Pressure-Product Parameters.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 2008, v. 13, n. 3, p. 175, doi. 10.1177/1074248408321571
- By:
- Publication type:
- Article
Pantoprazole effectively decreases the number of long reflux episodes by day 1 of therapy.
- Published in:
- 2003
- By:
- Publication type:
- Abstract